The Precision Medicine in Nephrology Program is comprised of researchers and clinicians at the University of Calgary’s Cumming School of Medicine who share common interests in understanding the molecular and genetic mechanisms of kidney disease to define disease specific biomarkers, develop advanced diagnostic testing and targeted treatments for patients with kidney disease.
Ultimately, our work is focused on using biospecimens, such as urine and blood samples, in advanced laboratory tests to produce evidence and data to support the integration of personalized testing and treatment options, known as "precision medicine," into clinical care.
We are working to achieve these goals through basic research projects, clinical research projects, large cohort studies (see the TARGET-KD Project), and by using our biobanking facility, the Biobank for the Molecular Classification of Kidney Disease (BMCKD), to translate molecular and genetic knowledge of kidney diseases to the care of these patients. We continue to invite collaborations with internal University of Calgary research groups as well as external investigators and sites throughout North America and Europe.
Snyder Institute for Chronic Diseases